文献速递消化、代谢与肾脏急症重症综合管理与镇静镇痛

重症监护病房中的急性胆管炎:临床、生物学、微生物学特征及死亡危险因素:一项多中心研究

Acute cholangitis in intensive care units: clinical, biological, microbiological spectrum and risk factors for mortality: a multicenter study.
PubMed 文献 · Crit Care · 2021-02-06
一句话结论ICU急性胆管炎患者住院死亡率29%,SOFA评分、乳酸、总胆红素、非胆石性梗阻、胆管炎并发症及胆道引流延迟>48 h与死亡独立相关。

这项回顾性多中心研究纳入2005至2018年11个ICU收治的382例确诊急性胆管炎成人患者,住院死亡率为29%,入院SOFA评分为8[5-11]。梗阻主要与胆石(53%)和肿瘤(22%)相关,63%血培养阳性,以革兰阴性杆菌为主(86%),14%产超广谱β-内酰胺酶。多因素分析显示入院SOFA评分、乳酸、总胆红素、非胆石性梗阻、胆管炎并发症及ICU入院至胆道减压>48 h与住院死亡独立相关,调整后死亡率逐年下降(每年OR 0.72[0.54-0.96],p=0.02)。

要点

  • ICU急性胆管炎住院死亡率为29%,入院SOFA评分为8[5-11],器官衰竭严重程度与死亡独立相关(每分OR 1.14[1.05-1.24],p=0.001)。
  • ICU入院至胆道减压>48 h与住院死亡独立相关(调整OR 2.73[1.30-6.22],p=0.02)。
  • 入院乳酸每升高1 mmol/L死亡风险增加(OR 1.21[1.08-1.36],p<0.001),总胆红素每升高50 μmol/L死亡风险增加(OR 1.26[1.12-1.41],p<0.001)。
  • 胆管炎并发症与住院死亡独立相关(OR 2.74[1.45-5.17],p=0.002),非胆石性梗阻亦与死亡相关(p<0.05)。
  • 调整后死亡率逐年下降,每年调整OR为0.72[0.54-0.96](p=0.02)。

适用人群与场景

  • 2005至2018年收治于11个ICU的成人确诊急性胆管炎患者,共382例。

处置流程与药物剂量

  • 胆道减压方式包括治疗性内镜逆行胰胆管造影(76%)和经皮肝穿刺胆道引流(21%)。

红旗征与不能漏的情况

  • ICU入院时持续性梗阻常见(79%)。
  • ICU入院至胆道减压>48 h与住院死亡独立相关(调整OR 2.73[1.30-6.22],p=0.02)。

研究设计与关键结果

  • 回顾性多中心研究纳入11个ICU的382例确诊急性胆管炎成人患者,住院死亡率为29%,入院SOFA评分为8[5-11]。
  • 梗阻主要与胆石(53%)和肿瘤(22%)相关;中位总胆红素83 µmol/L[50-147],中位降钙素原19.1 µg/L[5.3-54.8]。
  • 63%(n=252)血培养阳性,以革兰阴性杆菌为主(86%),14%产超广谱β-内酰胺酶。
  • ICU入院时持续性梗阻常见(79%),胆道减压采用治疗性内镜逆行胰胆管造影(76%)和经皮肝穿刺胆道引流(21%)。
  • 调整后死亡率逐年下降,每年调整OR为0.72[0.54-0.96](p=0.02)。
  • 多因素分析显示入院时与住院死亡相关的因素:SOFA评分(每分OR 1.14[95%CI 1.05-1.24],p=0.001)、乳酸(每1 mmol/L OR 1.21[95%CI 1.08-1.36],p<0.001)、总胆红素(每50 μmol/L OR 1.26[95%CI 1.12-1.41],p<0.001)、非胆石性梗阻(p<0.05)、胆管炎并发症(OR 2.74[95%CI 1.45-5.17],p=0.002)。
  • ICU入院至胆道减压>48 h与住院死亡相关(调整OR 2.73[95%CI 1.30-6.22],p=0.02)。

证据类型、等级与局限

  • 证据类型:回顾性多中心研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 本研究提示ICU急性胆管炎患者器官衰竭严重程度、梗阻原因及胆管炎局部并发症为死亡危险因素,胆道引流延迟>48 h亦与死亡相关。
  • 原文未据此给出推荐。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: Little is known on the outcome and risk factors for mortality of patients admitted in Intensive Care units (ICUs) for Acute cholangitis (AC).

METHODS: Retrospective multicenter study included adults admitted in eleven intensive care units for a proven AC from 2005 to 2018. Risk factors for in-hospital mortality were identified using multivariate analysis.

RESULTS: Overall, 382 patients were included, in-hospital mortality was 29%. SOFA score at admission was 8 [5-11]. Biliary obstruction was mainly related to gallstone (53%) and cancer (22%). Median total bilirubin and PCT were respectively 83 µmol/L [50-147] and 19.1 µg/L [5.3-54.8]. Sixty-three percent of patients (n = 252) had positive blood culture, mainly Gram-negative bacilli (86%) and 14% produced extended spectrum beta lactamase bacteria. At ICU admission, persisting obstruction was frequent (79%) and biliary decompression was performed using therapeutic endoscopic retrograde cholangiopancreatography (76%) and percutaneous transhepatic biliary drainage (21%). Adjusted mortality significantly decreased overtime, adjusted OR for mortality per year was 0.72 [0.54-0.96] (p = 0.02). In a multivariate analysis, factors at admission associated with in-hospital mortality were: SOFA score (OR 1.14 [95% CI 1.05-1.24] by point, p = 0.001), lactate (OR 1.21 [95% CI 1.08-1.36], by 1 mmol/L, p < 0.001), total serum bilirubin (OR 1.26 [95% CI 1.12-1.41], by 50 μmol/L, p < 0.001), obstruction non-related to gallstones (p < 0.05) and AC complications (OR 2.74 [95% CI 1.45-5.17], p = 0.002). Time between ICU admission and biliary decompression > 48 h was associated with in-hospital mortality (adjusted OR 2.73 [95% CI 1.30-6.22], p = 0.02).

CONCLUSIONS: In this large retrospective multicenter study, we found that AC-associated mortality significantly decreased overtime. Severity of organ failure, cause of obstruction and local complications of AC are risk factors for mortality, as well as delayed biliary drainage > 48 h.

来源:Crit Care,查看原文。版权归原作者所有。

参考来源

  1. Lavillegrand JR, Mercier-Des-Rochettes E, Baron E, et al. Acute cholangitis in intensive care units: clinical, biological, microbiological spectrum and risk factors for mortality: a multicenter study. Crit Care. 2021. PMID: 33549136. doi:10.1186/s13054-021-03480-1

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。